Grey Matter Neurosciences develops new medical devices and drug-device combinations to treat age-related brain illnesses.
Grey Matter Neurosciences has raised $14.0M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
Grey Matter Neurosciences's investors include Ontario Centre of Innovation, Wittington Ventures, Toronto Innovation Acceleration Partners, Ontario Brain Institute.
Grey Matter Neurosciences is headquartered in Toronto, Canada.
Grey Matter Neurosciences develops new medical devices and drug-device combinations to treat age-related brain illnesses.
Grey Matter Neurosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Grey Matter Neurosciences — Funding & Investors." VCBacked, January 23, 2025, https://www.vcbacked.co/company/grey-matter-neurosciences. Accessed October 31, 2026.
VCBacked. (2025). Grey Matter Neurosciences — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/grey-matter-neurosciences
{{cite web |title=Grey Matter Neurosciences — Funding & Investors |url=https://www.vcbacked.co/company/grey-matter-neurosciences |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated